SCHEMBL9486707

SCHEMBL9486707

O=C(Nc1ccc(C(F)(F)F)cc1)NS(=O)(=O)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.65
KMT2A Q03164 3/20 0.65
ALDH1A1 P00352 1/20 0.65
POLB P06746 1/20 0.65
EPHX2 P34913 2/20 0.60
CA12 O43570 2/20 0.58
CA1 P00915 2/20 0.58
CA2 P00918 2/20 0.58
CA9 Q16790 2/20 0.58
MAPT P10636 2/20 0.58
LMNA P02545 2/20 0.58
RAB9A P51151 2/20 0.56
NPC1 O15118 1/20 0.56
HRH3 Q9Y5N1 5/20 0.55
CYP2C9 P11712 1/20 0.55
IDH1 O75874 1/20 0.54
KCNH2 Q12809 1/20 0.54
NR1H3 Q13133 1/20 0.54
TP53 P04637 1/20 0.52
HTT P42858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24713415 0.92 CA12 (0.68) MEN1KMT2AALDH1A1POLBEPHX2
SCHEMBL9487281 0.87 CA1 (0.58) MEN1KMT2AALDH1A1POLBEPHX2
SCHEMBL12010912 0.87 NR1H3 (0.68) MEN1KMT2AALDH1A1POLBEPHX2
SCHEMBL7993424 0.86 TP53 (0.72) MEN1KMT2APOLBEPHX2CA12
SCHEMBL9488026 0.86 CNR2 (0.61) MEN1KMT2AEPHX2CA12CA1
SCHEMBL29771100 0.85 MAPT (0.69) MEN1KMT2AALDH1A1POLBCA12
SCHEMBL23447667 0.85 MAPT (0.69) MEN1KMT2AALDH1A1POLBCA12
SCHEMBL4196236 0.84 LMNA (0.78) EPHX2CA12CA1CA2CA9
SCHEMBL3346579 0.84 MAPT (0.68) MEN1KMT2AALDH1A1POLBEPHX2
SCHEMBL12010881 0.83 MEN1 (0.68) MEN1KMT2AALDH1A1POLBEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5260338-A Sulfonylureas ELI LILLY AND COMPANY (US) 1993-11-09 US disclosed
EP-0166615-B1 IMPROVEMENTS IN OR RELATING TO BENZENESULFONAMIDO DERIVATIVES ELI LILLY AND COMPANY (US) 1993-05-26 EP disclosed
US-5110830-A Benzenesulfonamides treatment of tumors susceptible to ELI LILLY AND COMPANY (US) 1992-05-05 US disclosed
US-4845128-A ANTITUMOR ELI LILLY AND COMPANY (US) 1989-07-04 US disclosed
US-4845128-A ANTITUMOR ELI LILLY AND COMPANY (US) 1989-07-04 US disclosed
EP-0166615-A2 Improvements in or relating to benzenesulfonamido derivatives ELI LILLY AND COMPANY (US) 1986-01-02 EP disclosed